| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.0002 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.002 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.21 | 0.002 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.089 | 0.003 |